Havana, Jun 10 (ACN) The renowned The Lancet Respiratory Medicine magazine published the successful clinical tests practiced for the Cuban vaccine Soberana Plus, which proved its effectiveness in reinforcing immunity against different variants of SARS-CoV-2.
On its Twitter account the Cuban Finlay Vaccines Institute wrote: The Lancet Respiratory Medicine magazine has just published the results of the clinical test phases 2a and 2 b of our vaccine Soberna Plus. This magazine is leader in this topic. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00100-X/fulltext
🇨🇺Noticia
— Instituto Finlay de Vacunas (@FinlayInstituto) June 10, 2022
Se acaba de publicar en la prestigiosa revista "The Lancet Respiratory Medicine" los resultados de los ensayos clínicos Fase 2a y 2b de nuestra vacuna #SoberanaPlus. Esta revista tiene un factor de impacto de 30.7 y es líder en el tema.
Acceso👉 https://t.co/xspkhyYfS8 pic.twitter.com/yQLARcwQGU
According to the Institute, Soberana Plus was designed as a booster capable of reactivating the pre-existing immune response, with potential protection against reinfections with new coronavirus strains, both for convalescents of the virus as well as people immunized with other vaccines.
The Lancet Respiratory Medicine magazine is world leader in research and is also a forum for expert opinions about medicine, government, and health systems.
Nos reservamos el derecho de no publicar los comentario que incumplan con las normas de este sitio